Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 8Terminated 3Unknown 2Recruiting 1

Sponsor Class

INDUSTRY 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 49Rectal Neoplasms 26Colonic Neoplasms 23Pancreatic Neoplasms 19Neoplasm Metastasis 17Neoplasms 13Stomach Neoplasms 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Esophageal Neoplasms 6Osteosarcoma 5Lymphoma, Non-Hodgkin 5Leukemia, Myeloid, Acute 5Burkitt Lymphoma 5Myelodysplastic Syndromes 4Gallbladder Neoplasms 4Adenocarcinoma Of Esophagus 4Triple Negative Breast Neoplasms 3Sarcoma 3Melanoma 3Lymphoma 3Lung Neoplasms 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hematologic Neoplasms 3Cholangiocarcinoma 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Bile Duct Neoplasms 3Somatostatinoma 2

Interventions

Gemcitabine 7Fluorouracil 5Cisplatin 5Leucovorin 3becatecarin 2Oxaliplatin 2Capecitabine 2trifluridine tipiracil drug combination 1trametinib 1titanium silicide 1spartalizumab 1seribantumab 1sargramostim 1pembrolizumab 1motexafin lutetium 1ixabepilone 1incomplete Freund's adjuvant 1durvalumab 1cediranib 1Trastuzumab 1Sutures 1Surgical Instruments 1Standard of Care 1S 1 (combination) 1Radiotherapy 1Radiosurgery 1Palonosetron 1Observation 1Liver Transplantation 1Ligation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Bile Duct Neoplasms × Leucovorin × Clear all
NCT05712356 2026-05-26

BOLSTER

Lisata Therapeutics, Inc.

Phase 2 Terminated
66 enrolled 12 charts
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Disease Progression

NCT01229111 2017-03-29

Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers

National Cancer Institute (NCI)

Phase 2 Terminated
14 enrolled 11 charts
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular

NCT00090025 2009-01-14

XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors

Helsinn Healthcare SA

Phase 3 Terminated
248 enrolled
Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡